Hard to tell. The potency assay development for the confirmatory heart trial, if one is needed as Dr. Perin has suggested, would be made much easier, of course, by a good understanding of the MoA and what biomarkers to use to predict and/or correlate with efficacy.
- Forums
- ASX - By Stock
- Clinical Trial-HF
Hard to tell. The potency assay development for the confirmatory...
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.16 |
Change
0.005(0.43%) |
Mkt cap ! $1.318B |
Open | High | Low | Value | Volume |
$1.15 | $1.17 | $1.13 | $3.743M | 3.261M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 78561 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.16 | 114667 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10200 | 1.170 |
3 | 10711 | 1.160 |
4 | 23567 | 1.155 |
4 | 23707 | 1.150 |
1 | 10700 | 1.145 |
Price($) | Vol. | No. |
---|---|---|
1.105 | 1443 | 2 |
1.130 | 5394 | 2 |
1.140 | 222 | 1 |
1.155 | 6209 | 3 |
1.160 | 123167 | 5 |
Last trade - 16.10pm 22/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |